Tele: 561.316.3330
Breaking Medical Device News

Monday, September 20, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeEXECUTIVESEarlySense Names John Dragovits as New SVP of Strategic Partnerships

EarlySense Names John Dragovits as New SVP of Strategic Partnerships

Matt Johnson, EarlySense CEO notes, “Partner collaboration has played an important role in EarlySense’s growth and has been instrumental in helping us reach our goal of establishing contact-free continuous monitoring as a standard of care.” Johnson added, “We look forward to tapping into John’s expertise to strengthen current strategic partnerships and help bring in new relationships that will enable us to continue to elevate patient safety and care.”

John Dragovits has more than 30 years of experience as a healthcare and healthcare IT executive leader. He previously served in VP roles with electronic health records companies Cerner Corporation (Nasdaq: CERN) as well as Senior Vice President and General Manager of Revenue Cycle at Allscripts (Nasdaq: MDX). He was also held health system senior executive roles, having served as Chief Financial Officer and Chief Operating Officer of Dallas’ Children’s Health and Executive VP and CFO of Parkland Health & Hospital System.  Mr. Dragovits is a former U.S. Navy Officer as well as a CPA and holds graduate and undergraduate degrees from Rice University.

“EarlySense is a recognized innovator within the patient monitoring markets, and has played an important role in advancing patient safety and outcomes in healthcare facilities worldwide,” said Dragovits. “I am honored to join the EarlySense team and to explore new avenues to bring contact-free continuous monitoring to even more patients, families and health teams.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Jonathan Chapman: New President/CEO of Trividia Health

Chapman said, “I’m honored to join the Trividia team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes.”

SOLOPASS® System (Bedside Neuro-Navigation Device) Receives FDA 510(k) Clearance

inTRAvent’s SOLOPASS® system brings simple, portable, bedside neuro-navigation into the intensive care unit.

By using this website you agree to accept Medical Device News Magazine Privacy Policy